How gene therapy targest liver cells [video]
February 20, 2014
(Scientific American) – Advances in gene therapy over the past 15 years are finally allowing investigators to safely treat a growing number of carefully selected patients with a broad range of defective or missing genes, as reported by Ricki Lewis in the March issue of Scientific American. One of the biggest obstacles researchers have learned to overcome is the immune system’s propensity to over-react when thousands of copies of the stripped-down viruses carrying normal genes are injected into the body, mistakenly treating them as foreign invaders.
